ADHD costs may rise 14-fold

Attention-deficiency hyperactivity disorder (ADHD) drug costs for the NHS are set to soar with increased diagnosis of the condition in children and adolescents in the UK, claim German researchers.

Predictions are that the estimated £7 million spend on ADHD by the NHS in 2002 will rise to between £49 and £101 million a year in 2012.

The overall drug expenditure by doctors for ADHD may increase between two- and nine-fold.

The estimates come from Professor Michael Schlander, from the University of Heidelberg.

He calculated the range of possible costs by considering likelihood of diagnosis and treatment, the level of treatment and drug costs.

rachel.liddle@haymarket.com

Visit the Child and Adolescent Psychiatry and Mental Health website

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Vaccination tracker

UK COVID-19 vaccination programme tracker

GPs across the UK have led the largest-ever NHS vaccination programme in response...

RCGP chair Professor Martin Marshall

Hand PCNs control of primary care infrastructure funding, says RCGP

CCG funding for primary care infrastructure should be handed to PCNs when the bodies...

Professor Martin Marshall and Talking General Practice logo

Podcast: RCGP chair Professor Martin Marshall

Talking General Practice speaks to RCGP chair Professor Martin Marshall.

Dr Chaand Nagpaul

In-house review not enough to stop 'unjust' GMC referrals, warns BMA

Doctors' leaders have repeated calls for a full independent review of the GMC referral...

Coronavirus

How widespread is long COVID in the UK?

Millions of people in the UK are living with long COVID. GPonline looks at the data...

COVID-19 vaccination sign

GP contract for autumn COVID-19 booster campaign due shortly

GP practices in England will be invited shortly to sign up for the COVID-19 autumn...